Author
Haiying Dong
Also Known As
DONG Hai-Ying, DONG Haiying, Dong Hai-Ying, Dong Haiying, Dong Haozhe, H. Dong, H.-Y. Dong, Hai-Ying Dong, Hai-ying DONG, Hai-ying Dong
263
Publications
1.1K
Citations
15
H-Index
89
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Engineering | 12 | 14 | 273 |
2 | Medicine | 4 | 4 | 191 |
3 | Public Health | 1 | 1 | 35 |
4 | Biochemistry | 1 | 1 | 60 |
5 | Biostatistics | 1 | 1 | 35 |
Haiying Dong
×
24
Publications
570
Citations
15
H-Index
| Year | Citations | |
|---|---|---|
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park, Metastatic Urothelial CancerUrologyGenitourinary CancerSelect Fgfr AlterationsMedicine | 2023 | 69 |
2023 | 60 | |
2021 | 53 | |
2022 | 50 | |
2003 | 35 | |
2020 | 27 | |
2020 | 27 | |
2012 | 22 | |
2023 | 21 | |
2022 | 20 |
Page 1
Page 1